CRISPR Therapeutics vs Emmecell
CRISPR Therapeutics vs Emmecell, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and Emmecell on 34/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 34/100
- domain rating: 67/100 against 9/100
Emmecell
- agent readiness: 50/100 against 44/100
At a glance
| Measure | CRISPR Therapeutics | Emmecell |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | Developing magnetic cell delivery platform for advanced therapies. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Biotechnology, HealthTech, Medical Devices, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2013 | 2016 |
| Headquarters | Zug, Switzerland | Menlo Park, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | Emmecell |
|---|---|---|
| Employees | Not published | 12 |
| Total funding | $547M | Not published |
| Latest round | Series B | Strategic |
| LinkedIn followers | Not published | 2,225 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | Emmecell |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 34/100 |
| Traction | 40/100 | 11/100 |
| Team | 70/100 | Not published |
| Search visibility | 13/100 | 25/100 |
| Quality | 88/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 9/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | Emmecell |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | Not detected | Wix |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CRISPR Therapeutics vs Emmecell: common questions
Which is better, CRISPR Therapeutics or Emmecell?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and Emmecell compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 34/100), domain rating (67/100 against 9/100). Emmecell leads on agent readiness (50/100 against 44/100).
Read the full CRISPR Therapeutics review and pricing or the Emmecell review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.